However, comorbidities may affect the treatment efficacy in preclinical models, e.g., the neuroprotective effect of IGF-1 following ischemic stroke was impaired in hypertensive rats, compared to normotensive rats (De Geyter et al., 2013). This evidence concerns the gene IGF1 and ischemic stroke.